Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer-Reference-Cited by-同舟云学术

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

Published:2012-10-18 Issue:11 Volume:107 Page:1892-1900
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Darb-Esfahani S,Kronenwett R,von Minckwitz G,Denkert C,Gehrmann M,Rody A,Budczies J,Brase J C,Mehta M K,Bojar H,Ataseven B,Karn T,Weiss E,Zahm D M,Khandan F,Dietel M,Loibl S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2012475.pdf

Reference33 articles.

1. Abdulrahman M, Maina EN, Morris MR, Zatyka M, Raval RR, Banks RE, Wiesener MS, Richards FM, Johnson CM, Latif F, Maher ER (2007) Identification of novel VHL targets that are associated with the development of renal cell carcinoma. Oncogene 26: 1661–1672

2. Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Rakha EA, Richardson AL, Schmitt FC, Tan PH, Tse GM, Weigelt B, Ellis IO, Reis-Filho JS (2011) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol 24: 157–167

3. Banyard J, Barrows C, Zetter BR (2009) Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1. Genes Chromosomes Cancer 48: 502–509

4. Bao L, Loda M, Janmey PA, Stewart R, Anand-Apte B, Zetter BR (1996) Thymosin beta 15: a novel regulator of tumour cell motility upregulated in metastatic prostate cancer. Nat Med 2: 1322–1328

5. Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkilä P, Heikkinen T, Nevanlinna H, Akslen LA, Bégin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, Rakha E, Green AR, Ellis IO, Sherman ME, Lissowska J, Anderson WF, Cox A, Cross SS, Reed MW, Provenzano E, Dawson SJ, Dunning AM, Humphreys M, Easton DF, García-Closas M, Caldas C, Pharoah PD, Huntsman D (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 7: e1000279

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome-based identification of key actin-binding proteins associated with high metastatic potential in breast cancer;Frontiers in Molecular Biosciences;2024-08-30

2. Immune-related gene characteristics: A new chapter in precision treatment of gastric cancer;World Journal of Gastrointestinal Oncology;2024-08-15

3. Construction of an immune-related gene signature for overall survival prediction and immune infiltration in gastric cancer;World Journal of Gastrointestinal Oncology;2024-03-15

4. Assessment of novel prognostic biomarkers to predict pathological complete response in patients with non-metastatic triple-negative breast cancer using a window of opportunity design;Therapeutic Advances in Medical Oncology;2024-01

5. Isoform switching leads to downregulation of cytokine producing genes in estrogen receptor positive breast cancer;Frontiers in Genetics;2023-10-13